Filter
1028
Filtered Results: 1028
Text search:
synthetic
drugs
Featured
Recommendations
99
New Publications
255
Language
Document type
No document type
571
Guidelines
187
Studies & Reports
169
Manuals
51
Strategic & Response Plan
30
Training Material
7
Fact sheets
7
Situation Updates
4
Resource Platforms
2
Countries / Regions
India
60
Global
35
Kenya
30
Nigeria
25
South Africa
25
Western and Central Europe
24
Ethiopia
19
Latin America and the Carribbean
17
Uganda
16
Zambia
15
Malawi
14
Sierra Leone
13
Liberia
13
Africa
12
Tanzania
12
Nepal
11
Rwanda
10
Bangladesh
10
Myanmar / Burma
9
Asia
8
Ukraine
7
Eastern Europe
7
Ghana
6
Lesotho
5
Russia
5
Zimbabwe
4
South–East Asia Region
4
Eastern Europe and Central Asia
4
Brazil
4
Namibia
4
Botswana
4
Thailand
3
Benin
3
Cameroon
3
Syria
3
Burkina Faso
3
Philippines
3
Guinea
3
USA
3
Cambodia
3
Venezuela
3
Vietnam
3
North Macedonia
2
Tajikistan
2
Turkey
2
Senegal
2
Afghanistan
2
Congo, Democratic Republic of
2
Moldova
2
Yemen
2
Indonesia
2
Mexico
1
Serbia
1
Kazakhstan
1
Chile
1
Canada
1
Singapore
1
Laos
1
Kyrgyzstan
1
Uzbekistan
1
Burundi
1
Peru
1
Morocco
1
Mozambique
1
Haiti
1
Germany
1
Western Pacific Region
1
North America
1
France
1
United Kingdom
1
Portugal
1
Spain
1
East and Southern Africa
1
Latvia
1
Argentina
1
Sudan
1
Georgia
1
Central African Republic
1
Chad
1
Libya
1
South Sudan
1
Iraq
1
Somalia
1
Solomon Islands
1
Madagascar
1
Eswatini/ Swaziland
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
323
Clinical Guidelines
123
Public Health
66
Women & Child Health
64
Key Resources
35
Pharmacy & Technologies
19
Capacity Building
11
Toolboxes
Mental Health
135
HIV
95
AMR
60
NTDs
47
COVID-19
44
TB
42
Pharmacy
42
Caregiver
26
Planetary Health
25
Rapid Response
18
NCDs
18
Refugee
17
Disability
16
Global Health Education
15
Ebola & Marburg
14
Conflict
8
Specific Hazards
6
Health Financing Toolbox
6
Polio
4
Cholera
3
Zika
3
Social Ethics
2
Malaria
2
Natural Hazards
1
This publication seeks to describe the best treatments and practices based on the scientific evidence available at the time of writing as evaluated by the authors and may change as a result of new research. Readers need to apply this knowledge to patients in accordance with the guidelines and laws o...
The internationally recognized criteria for diagnosis of neurocysticercosis include a requirement for neuroimaging techniques, such as computerized tomography (CT) and/or magnetic resonance imaging (MRI), ideally supported by serology. These facilities are not available in all settings, especially i...
Primary Surgery Vol. One: Non-Trauma
recommended
This comprehensive book has established itself as the most useful text for the medical practitioner in poor-resource settings who is obliged to manage surgical cases. It is particularly adapted for those whose surgical experience is basic or minimal. Importantly, it has extensive advice about pitfal...
Clinical guideline, Methods, Evidence and Recommendations
In this guideline the following is covered: information needs of people with chronic hep
titis B and their carers; where children, young people and adults with chronic hepatitis B a-
should be assessed; assessment of liver disease, includi...
The guidelines are to be used to guide the management of adults with lower respiratory tract infection (LRTI). As will be seen in the following text, this diagnosis, and the other clinical syndromes within this grouping, can be difficult to make accurately. In the absence of agreed definitions of th...
The larval stage of the parasite Taenia solium can encyst in the central nervous system causing neurocysticercosis, which is the main cause of acquired epilepsy in the countries in which the parasite is endemic. Endemic areas are those with the presence (or likely presence) of the full life cycle of...
This chapter discusses the antibacterial treatment of leprosy infections. Antibiotic treatment is
a key component of leprosy treatment, as it is vital to prevent the progression of the infection.
Treatment with rifampin and other antibiotics is highly effective and cures 98% of patients with
the ...
Known avoidable environmental risks to health cause at least 12.6 million deaths every year, and account for about one quarter of the global burden of disease (2016 data) (1). Air pollution alone causes about 7 million
deaths a year, placing it among the top global risks to health (2). Global envir...
Report on Main Findings
The review encompasses three complementary components: 1) a review of published literature 2000-2015 on NCDs and their risk factors; 2) qualitative interviews with key actors engaged in NCD research in Myanmar; and 3) additional reviews of Myanmar ethical committee inqui...
The review encompasses three complementary components: 1) a review of published literature 2000-2015 on NCDs and their risk factors; 2) qualitative interviews with key actors engaged in NCD research in Myanmar; and 3) additional reviews of Myanmar ethical committee inqui...
The United States Agency for International Development (USAID) Bureau for Democracy, Conflict, and Humanitarian Assistance Office of U.S. Foreign Disaster Assistance (DCHA/OFDA) requested Food and Nutrition Technical Assistance II Project (FANTA-2) assistance to review Community-Based Management of ...
Ahead of World Malaria Day, the WHO Global Malaria Programme published a new operational strategy outlining its priorities and key activities up to 2030 to help change the trajectory of malaria trends, with a view to achieving the global malaria targets. The strategy outlines 4 strategic objectives ...
6th edition, 2010. | Published in collaboration with World Health Organisation and Clinton Health Access Initiative.
Ethiopian Medicines Formulary
recommended
2nd edition
Fourth Edition
Accessed July 2014.
WHO’s Essential Medicines List and List of Essential Diagnostics are core guidance documents that help countries prioritize critical health products that should be widely available and affordable throughout health systems. The updated Essential Medicines List adds 23 medicines for children.
Namibia guideline for submission of applications for registration of pharmaceuticals for human use in common technical document format.
